Croda International, the company that uses smart science to create high performance ingredients and solutions that improve lives, has launched Matrixyl Neolide. This marks the next step in the evolution of one of the most widely recognised peptide technologies in skin care.

 

The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio, as it sharpens its position in premium beauty and personal care markets worldwide.

 

Since its debut in the 1990s, Matrixyl has built a strong reputation as a benchmark ingredient in advanced skin care, associated with firmer, healthier-looking skin. Now, with Matrixyl Neolide, Croda is extending that legacy with a patented encapsulation system designed to protect the peptide inside formulations and release it gradually after application.

 

The company says the approach delivers a more controlled, sustained performance profile, enabling peptide release for up to 15 days. By improving stability and predictability, the technology is aimed at helping brands develop more robust formulations, speed up product development, and scale more efficiently.

 

Sandra Breene, President of Consumer Care said: “Matrixyl has played a defining role in modern skin care, and Matrixyl Neolide represents a natural next step in its evolution. This innovation reflects how we are investing in technologies that not only enhance performance but also strengthen our growth platform in Consumer Care by helping customers succeed in fast moving, premium segments.”